Preclinical Evaluation of virus-like particle Vaccine Against Carbonic Anhydrase IX Efficacy in a Mouse Breast Cancer Model System
-
Published:2024-01-13
Issue:
Volume:
Page:
-
ISSN:1073-6085
-
Container-title:Molecular Biotechnology
-
language:en
-
Short-container-title:Mol Biotechnol
Author:
Kalniņa ZaneORCID, Liekniņa Ilva, Skeltona Vendija, Akopjana Ināra, Kazāks Andris, Tārs Kaspars
Funder
European Regional Development Fund
Publisher
Springer Science and Business Media LLC
Subject
Molecular Biology,Applied Microbiology and Biotechnology,Biochemistry,Bioengineering,Biotechnology
Reference53 articles.
1. Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71, 209–249. 2. Couzin-Frankel, J. (2013). Breakthrough of the year 2013. Cancer immunotherapy. Science, 342, 1432–1433. 3. Antonarelli, G., Corti, C., Tarantino, P., Ascione, L., Cortes, J., Romero, P., Mittendorf, E. A., Disis, M. L., & Curigliano, G. (2021). Therapeutic cancer vaccines revamping: Technology advancements and pitfalls. Annals of Oncology, 32, 1537–1551. 4. Buonaguro, L., & Tagliamonte, M. (2020). Selecting target antigens for cancer vaccine development. Vaccines (Basel). https://doi.org/10.3390/vaccines8040615 5. Pumpens, P., Renhofa, R., Dishlers, A., Kozlovska, T., Ose, V., Pushko, P., Tars, K., Grens, E., & Bachmann, M. F. (2016). The True Story and Advantages of RNA Phage Capsids as Nanotools. Intervirology, 59, 74–110.
|
|